{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:26:17Z","timestamp":1791012377366,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jconrel.2011.10.034","type":"journal-article","created":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T05:39:56Z","timestamp":1320817196000},"page":"194-199","source":"Crossref","is-referenced-by-count":15,"title":["Protection against TNF\u03b1-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNF\u03b1 in vivo"],"prefix":"10.1016","volume":"160","author":[{"given":"Patric","family":"Lundberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Behlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard M.","family":"Cantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2011.10.034_bb0005","first-page":"110","article-title":"Design of active small interfering RNAs","volume":"9","author":"Peek","year":"2007","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nprot.2006.72","article-title":"Rational design and in vitro and in vivo delivery of Dicer substrate siRNA","volume":"1","author":"Amarzguioui","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bioeng.2006.01.002","article-title":"RNA interference in cancer","volume":"23","author":"Gartel","year":"2006","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1359-6446(05)03668-8","article-title":"Harnessing in vivo siRNA delivery for drug discovery and therapeutic development","volume":"11","author":"Xie","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2011.10.034_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","article-title":"RNAi-mediated gene silencing in non-human primates","volume":"441","author":"Zimmermann","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2011.10.034_bb0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biochi.2005.11.010","article-title":"RNAi in mice: a promising approach to decipher gene functions in vivo","volume":"88","author":"Coumoul","year":"2006","journal-title":"Biochimie"},{"key":"10.1016\/j.jconrel.2011.10.034_bb0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.it.2006.05.006","article-title":"Interfering antiviral immunity: application, subversion, hope?","volume":"27","author":"Manjunath","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0040","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1517\/14712598.7.12.1811","article-title":"Polycation-based nanoparticle delivery for improved RNA interference therapeutics","volume":"7","author":"Howard","year":"2007","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/hum.2008.928","article-title":"Delivery vehicles for small interfering RNA in vivo","volume":"19","author":"de Fougerolles","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1758-907X-1-14","article-title":"A status report on RNAi therapeutics","volume":"1","author":"Vaishnaw","year":"2010","journal-title":"Silence"},{"key":"10.1016\/j.jconrel.2011.10.034_bb0060","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/JVI.02243-06","article-title":"Tumor necrosis factor (TNF) protects resistant C57BL\/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2","volume":"81","author":"Lundberg","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0065","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1128\/JVI.00619-08","article-title":"The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of CNS pathology resulting in fatal encephalitis","volume":"82","author":"Lundberg","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-2836(03)00181-5","article-title":"Gene silencing by systemic delivery of synthetic siRNAs in adult mice","volume":"327","author":"Sorensen","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt1051","article-title":"Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy","volume":"23","author":"Kim","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0080","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1093\/nar\/gki732","article-title":"Functional polarity is introduced by Dicer processing of short substrate RNAs","volume":"33","author":"Rose","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0085","doi-asserted-by":"crossref","first-page":"R1196","DOI":"10.1152\/ajpregu.2000.278.5.R1196","article-title":"Lipopolysaccharide and d-galactosamine-induced hepatic injury is mediated by TNF-\u0152\u00b1 and not by Fas ligand","volume":"278","author":"Josephs","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0090","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.cgt.7700156","article-title":"Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer","volume":"7","author":"Zou","year":"2000","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/oli.2009.0180","article-title":"siRNA and innate immunity","volume":"19","author":"Robbins","year":"2009","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.jconrel.2011.10.034_bb0100","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.mt.6300240","article-title":"2\u2032-O-methyl-modified RNAs act as TLR7 antagonists","volume":"15","author":"Robbins","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/oli.2008.0164","article-title":"Chemical modification of siRNAs for in vivo use","volume":"18","author":"Behlke","year":"2008","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.jconrel.2011.10.034_bb0110","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.76.11.5939","article-title":"Galactosamine-induced sensitization to the lethal effects of endotoxin","volume":"76","author":"Galanos","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-alpha signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2011.10.034_bb0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.shk.0000191343.21228.78","article-title":"Neutralization of tumor necrosis factor in preclinical models of sepsis","volume":"24","author":"Lorente","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.jconrel.2011.10.034_bb0130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ymthe.2006.04.010","article-title":"RNA interference in vitro and in vivo using a novel chitosan\/siRNA nanoparticle system","volume":"14","author":"Howard","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/mt.2008.220","article-title":"Chitosan\/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model","volume":"17","author":"Howard","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2010.09.010","article-title":"Intraperitoneal administration of chitosan\/DsiRNA nanoparticles targeting TNFalpha prevents radiation-induced fibrosis","volume":"97","author":"Nawroth","year":"2010","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.jconrel.2011.10.034_bb0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11095-009-0031-z","article-title":"Drug delivery systems for intraperitoneal therapy","volume":"27","author":"Bajaj","year":"2010","journal-title":"Pharm. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911010273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911010273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T04:46:16Z","timestamp":1560919576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365911010273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0168365911010273"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.10.034","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}